The biomedical paradigm is implicated in the corporate construction of psychosis with the pharmaceutical industry.
There are major conceptual and empirical problems with this construction.
The psychosocial paradigm changes the meaning of psychosis within recovery and provides values- and evidence-based alternative interventions.
This places a demand on mental health nurse education internationally to take a moral lead in revising its curricular and pedagogic practises.